Public source

Reviewed 11 May 2026

Completeness Fair (28%)

Duali-Q

IMedis

IMedis Duali-Q aims to optimize the QA process by performing automatic QA on every CT scan and accompanying report to uncover actionable failure points, helping to enhance radiology performance, reducing the risk to providers and improving outcomes for patients.

No papers to support — we monitor for new evidence.

Key features

Pancreatic lesions

Pulmonary nodules

Radiology report assessment of liver lesions

Thoracic and abdominal aorta dilation.

General Information

Product name

Duali-Q

Company

Modality

CT

Main task

Not specified

Subspeciality

Abdomen, Chest

Disease targeted

Liver cancer, lung cancer, pancreatic cancer, aorta dilation

Regulatory Information

CE Certification

Pathway:

MDD

Class:

Class I

Not verified by Health AI Register

Other certifications

Not specified

Evidence & Research

No research papers or evidence on file yet.

The registry monitors publications for new evidence.

Technical Specifications

Patient population age

Not specified

Input

Not specified

Input format

Not specified

Output

Not specified

Output format

Not specified

Integration

Not specified

Deployment

Not specified

Trigger for analysis

Not specified

Processing time

Not specified

Population

Not specified

Market Presence

On market since

Not specified

AI Platforms

Resellers

Not specified

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Not specified

Based on

Not specified

Source: Public | First published: Oct 25, 2022 | Last updated: May 11, 2026